Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial

详细信息    查看全文

• 作者：Craig A McBride ; Roy M Kimble ; Kellie Stockton
• 关键词：Pediatric ; Burns ; Split ; thickness skin graft ; Donor site ; Dressing ; Randomised controlled trial ; Pain ; Scar ; Itch ; Re ; epithelialisation
• 刊名：Trials
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：16
• 期：1
• 全文大小：624 KB
• 参考文献：1. Lars PKLP, Giretzlehner M, Trop M, Parvizi D, Spendel S, Schintler M, et al. The properties of the “ideal-donor site dressing: results of a worldwide online survey. Ann Burns Fire Disasters. 2013;26:136-1.
  2. Lyall PW, Sinclair SW. Australasian survey of split skin graft donor site dressings. Aust N Z J Surg. 2000;70:114-. 22.2000.01767.x" target="_blank" title="It opens in new window">CrossRef
  3. Geary PM, Tiernan E. Management of split skin graft donor sites–results of a national survey. Clin Plast Surg. 2012;39:77-4. 2011.09.012" target="_blank" title="It opens in new window">CrossRef
  4. Vermeulen H, Ubbink DT, de Zwart F, Goossens A, de Vos R. Preferences of patients, doctors, and nurses regarding wound dressing characteristics: a conjoint analysis. Wound Repair Regen. 2007;15:302-. 24-475X.2007.00230.x" target="_blank" title="It opens in new window">CrossRef
  5. Birchall MA, Varma S, Milward TM. The Moriarty sign: an appraisal. Br J Plast Surg. 1991;44:149-0. 226(91)90051-K" target="_blank" title="It opens in new window">CrossRef
  6. Miller K, Rodger S, Kipping B, Kimble RM. A novel technology approach to pain management in children with burns: a prospective randomized controlled trial. Burns. 2011;37:395-05. burns.2010.12.008" target="_blank" title="It opens in new window">CrossRef
  7. Brown NJ, Kimble RM, Rodger S, Ware RS, Cuttle L. Play and heal: randomized controlled trial of Ditto?intervention efficacy on improving re-epithelialization in pediatric burns. Burns. 2014;40:204-3. burns.2013.11.024" target="_blank" title="It opens in new window">CrossRef
  8. Brown NJ, Kimble RM, Gramotnev G, Rodger S, Cuttle L. Predictors of re-epithelialization in pediatric burn. Burns. 2014;40:751-. burns.2013.09.027" target="_blank" title="It opens in new window">CrossRef
  9. Kishikova L, Smith MD, Cubison TCS. Evidence based management for paediatric burn: new approaches and improved scar outcomes. Burns. 2014;40:1530-. burns.2014.01.020" target="_blank" title="It opens in new window">CrossRef
  10. Voineskos SH, Ayeni OA, McKnight L, Thoma A. Systematic review of skin graft donor-site dressings. Plast Reconstr Surg. 2009;124:298-06. 2f" target="_blank" title="It opens in new window">CrossRef
  11. Rakel BA, Bermel MA, Abbott LI, Baumler SK, Burger MR, Dawson CJ, et al. Split-thickness skin graft donor site care: a quantitative synthesis of the research. Appl Nurs Res. 1998;11:174-2. 296-6" target="_blank" title="It opens in new window">CrossRef
  12. Wiechula R. The use of moist wound-healing dressings in the management of split-thickness skin graft donor sites: a systematic review. Int J Nurs Pract. 2003;9:S9–S17. 22-7114.2003.00417.x" target="_blank" title="It opens in new window">CrossRef
  13. Schreuder SM, Vermeulen H, Qureshi MA, Ubbink DT. Dressings and topical agents for treating donor sites of split-skin grafts: a systematic review [abstract]. Cochrane Database Syst Rev. 2009:22(4).
  14. Randomised controlled trial of donor site dressings in paediatric split skin grafts. Australian New Zealand Clinical Trials Registry. 2007. [2" class="a-plus-plus">https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366062]. Accessed 22 Jan 2015.
  15. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32. 215-11-32" target="_blank" title="It opens in new window">CrossRef
  16. Probst A, Norris R, Cutting KF. Cutimed Sorbact? made easy. Wounds Int. 2012;3(2).
  17. Ahmadi H, Durrant C, Williams G. Permanent scarring in a scald burn dressed with paraffin gauze. J Wound Care. 2009;18:256-. 2968/jowc.2009.18.6.42805" target="_blank" title="It opens in new window">CrossRef
  18. Raza MS, Nazim T, Khan FA. Comparison of bupivacaine moistened dressing and conventional dressing for pain relief on skin graft donor sites. J Coll Physicians Surg Pak. 2014;24:416-.
  19. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infecti
• 刊物主题：Medicine/Public Health, general; Biomedicine general; Statistics for Life Sciences, Medicine, Health Sciences;
• 出版者：BioMed Central
• ISSN：1745-6215

文摘

Background For children requiring split-thickness skin grafting for burn injury, the optimum donor site dressing is an ongoing subject of debate. The most common dressings in use, both regionally and worldwide, are calcium alginates. We will compare an alginate with two other dressings, all of which are in current use in the Pegg Leditschke Paediatric Burns Centre (PLPBC), to determine which dressing performs the best. Methods/Design This is a randomised, prospective single center parallel three-arm trial comparing three donor site wound (DSW) dressings: Algisite?M, a calcium alginate dressing; Cuticerin? a smooth acetate gauze impregnated with water-repellent ointment (petrolatum, paraffin and Eucerite?) and Sorbact?, a gauze mesh coated with a dialkylcarbamoyl chloride (DACC) and amorphous hydrogel. Primary outcomes are days to complete DSW healing, and pain. Previously validated measures will be used for all outcomes. Secondary outcomes are: itch; scar appearance at three, six and 12?months; ease of dressing application and removal and dressing costs and utility. Results will be analysed on an intention-to-treat basis. Donor site thickness will be measured with a small biopsy from the center of the graft, to document the depth of the DSW across the groups. Discussion This study will provide comprehensive short- and long-term data on DSW dressings in pediatric split-thickness skin grafting. The best-performing dressing will become the preferred dressing for the PLPBC. We will provide rigorous data against which other dressings can be compared in future, recognising that alginates are the most common DSW dressing currently in use. Our study design replicates a real-world scenario in order to identify clinically significant differences between the three dressings. Trial registration This trial was prospectively registered on 8 April 2014 with the Australia and New Zealand Clinical Trials Register (identifier: ACTRN12614000380695).